← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Diabetes Technology and Therapeutics (ISSN 1520-9156, 1557-8593) is a journal published by Mary Ann Liebert Inc. in the United States. It covers Biochemistry, Genetics and Molecular Biology, Health Professions and Medicine. It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 7.4, Scopus Q1, Web of Science Q1, CiteScore 10.5 and HEC W-Category. Article processing charge: USD 4,710.

Journal title

Diabetes Technology and Therapeutics

About the journal
—
ISSN
1520-9156, 1557-8593
Publisher
Mary Ann Liebert Inc.
Country
United States
Subject area
BiochemistryGenetics and Molecular BiologyHealth ProfessionsMedicineEndocrinologyEndocrinology & Diabetes and MetabolismMedical Laboratory TechnologyMedicine (miscellaneous)
SJR
2.663
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Open access
No
APC (USD)
4710
SCImago Ranking
875
WoS Status
Science Citation Index Expanded (SCIE)
HEC
W-Category
Journal Website
journals.sagepub.com/home/DTT ↗
WoS Quartile
Q1
Registered In
1999
Instructions for Authors URL
—
Average Time To Publication After Submission (In Weeks)
—
APC Information URL
—
Waiver policy
—
Has any other fees
—
Impact Factor
7.4
Scopus URL
www.scopus.com/sourceid/25545 ↗
Scopus Cite Score
10.5
Aims and Scope
—
Scopus Quartile
Q1

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Browse similar journals